_MEMBER_MyList,_LogP_MyList,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,-2.6,GO:0048589,developmental growth,M1,1,0
1,-4.3,GO:0051345,positive regulation of hydrolase activity,M1,1,0
1,-2.5,GO:0070663,regulation of leukocyte proliferation,M1,1,0
1,-3.1,hsa05206,MicroRNAs in cancer,M1,1,0
1,-3,R-HSA-69202,Cyclin E associated events during G1/S transition,M1,1,0
1,-3.2,GO:0120035,regulation of plasma membrane bounded cell projection organization,M1,1,0
1,-3.7,GO:0021872,forebrain generation of neurons,M1,1,0
1,-5.3,GO:0032872,regulation of stress-activated MAPK cascade,M1,1,0
1,-3.4,GO:0038127,ERBB signaling pathway,M1,1,0
1,-4.8,hsa04014,Ras signaling pathway,M1,1,0
1,-2.6,GO:0007283,spermatogenesis,M1,1,0
1,-2.5,GO:0043244,regulation of protein-containing complex disassembly,M1,1,0
1,-6.1,hsa05214,Glioma,M1,1,0
1,-3.8,GO:0006006,glucose metabolic process,M1,1,0
1,-5,GO:0045604,regulation of epidermal cell differentiation,M1,1,0
1,-3.2,GO:0051054,positive regulation of DNA metabolic process,M1,1,0
1,-2.9,hsa04015,Rap1 signaling pathway,M1,1,0
1,-2.8,GO:0021510,spinal cord development,M1,1,0
1,-2.5,GO:0032943,mononuclear cell proliferation,M1,1,0
1,-3.1,GO:0007599,hemostasis,M1,1,0
1,-2.9,WP138,Androgen receptor signaling pathway,M1,1,0
1,-7.3,hsa05210,Colorectal cancer,M1,1,0
1,-4.2,GO:0045321,leukocyte activation,M1,1,0
1,-8.4,WP4239,Epithelial to mesenchymal transition in colorectal cancer,M1,1,0
1,-2,GO:0042326,negative regulation of phosphorylation,M1,1,0
1,-5,M100,PID SHP2 PATHWAY,M1,1,0
1,-2.2,GO:0051301,cell division,M1,1,0
1,-2.8,GO:1905477,positive regulation of protein localization to membrane,M1,1,0
1,-2.8,hsa05163,Human cytomegalovirus infection,M1,1,0
1,-6.3,hsa05207,Chemical carcinogenesis - receptor activation,M1,1,0
1,-3.6,R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),M1,1,0
1,-2.6,GO:0030326,embryonic limb morphogenesis,M1,1,0
1,-2.3,R-HSA-453279,Mitotic G1 phase and G1/S transition,M1,1,0
1,-4.9,GO:0030111,regulation of Wnt signaling pathway,M1,1,0
1,-2.4,hsa04910,Insulin signaling pathway,M1,1,0
1,-6.1,GO:0033135,regulation of peptidyl-serine phosphorylation,M1,1,0
1,-3.1,GO:0031056,regulation of histone modification,M1,1,0
1,-16,WP5087,Malignant pleural mesothelioma,M1,1,0
1,-3.9,GO:0071695,anatomical structure maturation,M1,1,0
1,-5.7,GO:0090066,regulation of anatomical structure size,M1,1,0
1,-3,GO:0046890,regulation of lipid biosynthetic process,M1,1,0
1,-2.8,GO:0071396,cellular response to lipid,M1,1,0
1,-2.1,GO:1902107,positive regulation of leukocyte differentiation,M1,1,0
1,-10,GO:0048729,tissue morphogenesis,M1,1,0
1,-4.1,hsa04914,Progesterone-mediated oocyte maturation,M1,1,0
1,-3.7,M288,PID HES HEY PATHWAY,M1,1,0
1,-2.3,GO:0070661,leukocyte proliferation,M1,1,0
1,-2.5,GO:0032874,positive regulation of stress-activated MAPK cascade,M1,1,0
1,-2.2,R-HSA-69242,S Phase,M1,1,0
1,-6.2,GO:0032868,response to insulin,M1,1,0
1,-9.4,GO:0002009,morphogenesis of an epithelium,M1,1,0
1,-5,GO:0051090,regulation of DNA-binding transcription factor activity,M1,1,0
1,-3.1,GO:0003151,outflow tract morphogenesis,M1,1,0
1,-4.3,GO:0051099,positive regulation of binding,M1,1,0
1,-3,GO:0032990,cell part morphogenesis,M1,1,0
1,-4.2,GO:0009798,axis specification,M1,1,0
1,-3.7,WP4217,Ebola virus infection in host,M1,1,0
1,-3.3,GO:0048592,eye morphogenesis,M1,1,0
1,-3.2,M40,PID E2F PATHWAY,M1,1,0
1,-2.4,GO:0030099,myeloid cell differentiation,M1,1,0
1,-6.2,GO:0001934,positive regulation of protein phosphorylation,M1,1,0
1,-2.5,GO:0046651,lymphocyte proliferation,M1,1,0
1,-3.4,GO:0048667,cell morphogenesis involved in neuron differentiation,M1,1,0
1,-2.6,GO:0033044,regulation of chromosome organization,M1,1,0
1,-5.3,R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,M1,1,0
1,-5.3,GO:0043549,regulation of kinase activity,M1,1,0
1,-2.9,GO:1901215,negative regulation of neuron death,M1,1,0
1,-7.8,GO:0001654,eye development,M1,1,0
1,-14,hsa05217,Basal cell carcinoma,M1,1,0
1,-4.3,GO:0048545,response to steroid hormone,M1,1,0
1,-2.4,M145,PID P53 DOWNSTREAM PATHWAY,M1,1,0
1,-3.3,GO:0019318,hexose metabolic process,M1,1,0
1,-4.4,WP2261,Glioblastoma signaling pathways,M1,1,0
1,-6,R-HSA-201681,TCF dependent signaling in response to WNT,M1,1,0
1,-3.1,hsa05220,Chronic myeloid leukemia,M1,1,0
1,-2.7,GO:0043467,regulation of generation of precursor metabolites and energy,M1,1,0
1,-2.5,GO:0003231,cardiac ventricle development,M1,1,0
1,-2.1,GO:0001933,negative regulation of protein phosphorylation,M1,1,0
1,-2.6,R-HSA-8878166,Transcriptional regulation by RUNX2,M1,1,0
1,-2.5,GO:0009410,response to xenobiotic stimulus,M1,1,0
1,-3.4,GO:0051091,positive regulation of DNA-binding transcription factor activity,M1,1,0
1,-3.4,GO:0001558,regulation of cell growth,M1,1,0
1,-3.7,GO:0045860,positive regulation of protein kinase activity,M1,1,0
1,-5,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,M1,1,0
1,-7.7,GO:0048880,sensory system development,M1,1,0
1,-3.9,WP4172,PI3K-Akt signaling pathway,M1,1,0
1,-3.5,GO:0006325,chromatin organization,M1,1,0
1,-6.2,hsa05218,Melanoma,M1,1,0
1,-2.4,GO:0009799,specification of symmetry,M1,1,0
1,-2.9,R-HSA-8878159,Transcriptional regulation by RUNX3,M1,1,0
1,-6.5,GO:0051897,positive regulation of protein kinase B signaling,M1,1,0
1,-2.6,GO:0032944,regulation of mononuclear cell proliferation,M1,1,0
1,-4.9,GO:0030010,establishment of cell polarity,M1,1,0
1,-2.5,GO:1904375,regulation of protein localization to cell periphery,M1,1,0
1,-2.1,GO:1905475,regulation of protein localization to membrane,M1,1,0
1,-3.1,GO:0048858,cell projection morphogenesis,M1,1,0
1,-6.6,GO:0043009,chordate embryonic development,M1,1,0
1,-4,GO:1903524,positive regulation of blood circulation,M1,1,0
1,-6.2,R-HSA-372790,Signaling by GPCR,M1,1,0
1,-2.9,GO:0034330,cell junction organization,M1,1,0
1,-2.1,GO:0051302,regulation of cell division,M1,1,0
1,-3.4,GO:1904036,negative regulation of epithelial cell apoptotic process,M1,1,0
1,-8.2,WP710,DNA damage response (only ATM dependent),M1,1,0
1,-2.8,GO:0019218,regulation of steroid metabolic process,M1,1,0
1,-2.3,hsa04072,Phospholipase D signaling pathway,M1,1,0
1,-3.1,GO:0031344,regulation of cell projection organization,M1,1,0
1,-3.1,GO:0001501,skeletal system development,M1,1,0
1,-4.2,GO:0040029,epigenetic regulation of gene expression,M1,1,0
1,-5,R-HSA-2644603,Signaling by NOTCH1 in Cancer,M1,1,0
1,-2.6,GO:0040007,growth,M1,1,0
1,-2.9,GO:0021766,hippocampus development,M1,1,0
1,-4.1,GO:0030308,negative regulation of cell growth,M1,1,0
1,-2.9,WP4658,Small cell lung cancer,M1,1,0
1,-3.1,GO:0045580,regulation of T cell differentiation,M1,1,0
1,-9.5,WP4787,Osteoblast differentiation and related diseases,M1,1,0
1,-2.2,GO:0051493,regulation of cytoskeleton organization,M1,1,0
1,-5.5,WP4540,Hippo signaling regulation pathways,M1,1,0
1,-3.9,M5883,NABA SECRETED FACTORS,M1,1,0
1,-3.7,GO:0002761,regulation of myeloid leukocyte differentiation,M1,1,0
1,-2.4,WP2884,NRF2 pathway,M1,1,0
1,-4,GO:1902105,regulation of leukocyte differentiation,M1,1,0
1,-4.5,hsa05160,Hepatitis C,M1,1,0
1,-4.8,WP3680,Physico-chemical features and toxicity-associated pathways,M1,1,0
1,-6.4,R-HSA-3238698,WNT ligand biogenesis and trafficking,M1,1,0
1,-2.3,GO:0035108,limb morphogenesis,M1,1,0
1,-4,M41,PID ER NONGENOMIC PATHWAY,M1,1,0
1,-2.7,GO:0001678,intracellular glucose homeostasis,M1,1,0
1,-3.2,GO:0048332,mesoderm morphogenesis,M1,1,0
1,-2.6,GO:0043200,response to amino acid,M1,1,0
1,-4.6,WP51,Regulation of actin cytoskeleton,M1,1,0
1,-4.9,GO:0007167,enzyme-linked receptor protein signaling pathway,M1,1,0
1,-4,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,M1,1,0
1,-4.8,M101,PID HDAC CLASSI PATHWAY,M1,1,0
1,-3,GO:0042113,B cell activation,M1,1,0
1,-4.3,GO:0048762,mesenchymal cell differentiation,M1,1,0
1,-5.4,GO:0045639,positive regulation of myeloid cell differentiation,M1,1,0
1,-4.1,GO:0007517,muscle organ development,M1,1,0
1,-3.1,hsa05212,Pancreatic cancer,M1,1,0
1,-7.7,GO:0009952,anterior/posterior pattern specification,M1,1,0
1,-4.4,GO:0001837,epithelial to mesenchymal transition,M1,1,0
1,-5.7,GO:0045926,negative regulation of growth,M1,1,0
1,-28,hsa05224,Breast cancer,M1,1,0
1,-3.1,GO:0048644,muscle organ morphogenesis,M1,1,0
1,-4.4,GO:0030900,forebrain development,M1,1,0
1,-6,R-HSA-9009391,Extra-nuclear estrogen signaling,M1,1,0
1,-4.5,GO:0060828,regulation of canonical Wnt signaling pathway,M1,1,0
1,-4.4,WP4806,EGFR tyrosine kinase inhibitor resistance,M1,1,0
1,-4.2,GO:0035282,segmentation,M1,1,0
1,-2.7,GO:0051341,regulation of oxidoreductase activity,M1,1,0
1,-3.4,GO:0120161,regulation of cold-induced thermogenesis,M1,1,0
1,-12,GO:0007423,sensory organ development,M1,1,0
1,-2.1,WP5316,Primary ovarian insufficiency,M1,1,0
1,-3.3,GO:0045834,positive regulation of lipid metabolic process,M1,1,0
1,-2.9,GO:0046330,positive regulation of JNK cascade,M1,1,0
1,-3.2,GO:0001707,mesoderm formation,M1,1,0
1,-4.9,GO:0021516,dorsal spinal cord development,M1,1,0
1,-5.4,GO:0001944,vasculature development,M1,1,0
1,-2.3,GO:0061458,reproductive system development,M1,1,0
1,-3.8,GO:1901861,regulation of muscle tissue development,M1,1,0
1,-4,GO:0071392,cellular response to estradiol stimulus,M1,1,0
1,-3.9,GO:0043410,positive regulation of MAPK cascade,M1,1,0
1,-21,hsa05200,Pathways in cancer,M1,1,0
1,-5.2,GO:0048514,blood vessel morphogenesis,M1,1,0
1,-3.6,GO:2000677,regulation of transcription regulatory region DNA binding,M1,1,0
1,-3.6,R-HSA-2428924,IGF1R signaling cascade,M1,1,0
1,-2.6,GO:1904029,regulation of cyclin-dependent protein kinase activity,M1,1,0
1,-10,hsa04390,Hippo signaling pathway,M1,1,0
1,-4.3,WP2840,Hair follicle development: cytodifferentiation - part 3 of 3,M1,1,0
1,-3.6,WP560,TGF-beta receptor signaling,M1,1,0
1,-5.5,WP2873,Aryl hydrocarbon receptor pathway,M1,1,0
1,-4.1,GO:0048661,positive regulation of smooth muscle cell proliferation,M1,1,0
1,-3,GO:0062012,regulation of small molecule metabolic process,M1,1,0
1,-4,GO:1901699,cellular response to nitrogen compound,M1,1,0
1,-2.3,hsa04218,Cellular senescence,M1,1,0
1,-5.8,GO:0071363,cellular response to growth factor stimulus,M1,1,0
1,-4.6,GO:0001570,vasculogenesis,M1,1,0
1,-3,GO:0009743,response to carbohydrate,M1,1,0
1,-2,GO:0090276,regulation of peptide hormone secretion,M1,1,0
1,-3,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,M1,1,0
1,-2.2,GO:0050796,regulation of insulin secretion,M1,1,0
1,-5.7,GO:0002520,immune system development,M1,1,0
1,-2.2,GO:0071496,cellular response to external stimulus,M1,1,0
1,-2.7,GO:0001818,negative regulation of cytokine production,M1,1,0
1,-2.5,GO:0016051,carbohydrate biosynthetic process,M1,1,0
1,-2.5,GO:0090068,positive regulation of cell cycle process,M1,1,0
1,-2.2,GO:0042110,T cell activation,M1,1,0
1,-2.9,WP673,ErbB signaling pathway,M1,1,0
1,-3.8,WP2586,Aryl hydrocarbon receptor pathway,M1,1,0
1,-3.4,GO:0009749,response to glucose,M1,1,0
1,-3,GO:1903131,mononuclear cell differentiation,M1,1,0
1,-3.1,GO:0048863,stem cell differentiation,M1,1,0
1,-12,GO:0009725,response to hormone,M1,1,0
1,-4.5,R-HSA-1227990,Signaling by ERBB2 in Cancer,M1,1,0
1,-3,GO:1904951,positive regulation of establishment of protein localization,M1,1,0
1,-3.7,hsa04810,Regulation of actin cytoskeleton,M1,1,0
1,-2.1,R-HSA-9824446,Viral Infection Pathways,M1,1,0
1,-8.4,WP2059,Alzheimer's disease and miRNA effects,M1,1,0
1,-5.2,R-HSA-9665348,Signaling by ERBB2 ECD mutants,M1,1,0
1,-3.7,GO:0090102,cochlea development,M1,1,0
1,-2.9,GO:0010001,glial cell differentiation,M1,1,0
1,-2,GO:0043433,negative regulation of DNA-binding transcription factor activity,M1,1,0
1,-3,GO:0010660,regulation of muscle cell apoptotic process,M1,1,0
1,-4.6,R-HSA-1643713,Signaling by EGFR in Cancer,M1,1,0
1,-5.3,hsa04066,HIF-1 signaling pathway,M1,1,0
1,-2.4,GO:0010565,regulation of cellular ketone metabolic process,M1,1,0
1,-3,GO:0001819,positive regulation of cytokine production,M1,1,0
1,-5.3,GO:0048839,inner ear development,M1,1,0
1,-3.1,GO:0021953,central nervous system neuron differentiation,M1,1,0
1,-3.6,GO:0035914,skeletal muscle cell differentiation,M1,1,0
1,-2.5,GO:0045931,positive regulation of mitotic cell cycle,M1,1,0
1,-5,GO:0043583,ear development,M1,1,0
1,-3.1,M115,PID REG GR PATHWAY,M1,1,0
1,-5.6,GO:0030856,regulation of epithelial cell differentiation,M1,1,0
1,-2.5,GO:0060972,left/right pattern formation,M1,1,0
1,-7.2,GO:0007507,heart development,M1,1,0
1,-2.4,hsa04936,Alcoholic liver disease,M1,1,0
1,-2.2,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,M1,1,0
1,-8.1,GO:0048598,embryonic morphogenesis,M1,1,0
1,-4.4,GO:0042692,muscle cell differentiation,M1,1,0
1,-4.7,GO:0032535,regulation of cellular component size,M1,1,0
1,-5.2,R-HSA-9758941,Gastrulation,M1,1,0
1,-4.6,GO:0001890,placenta development,M1,1,0
1,-5.9,GO:0032869,cellular response to insulin stimulus,M1,1,0
1,-3.7,GO:0071900,regulation of protein serine/threonine kinase activity,M1,1,0
1,-10,hsa05215,Prostate cancer,M1,1,0
1,-2.5,GO:2000027,regulation of animal organ morphogenesis,M1,1,0
1,-3.8,GO:0032355,response to estradiol,M1,1,0
1,-8.9,hsa05010,Alzheimer disease,M1,1,0
1,-19,hsa05225,Hepatocellular carcinoma,M1,1,0
1,-5.2,GO:0070302,regulation of stress-activated protein kinase signaling cascade,M1,1,0
1,-2.9,GO:1900182,positive regulation of protein localization to nucleus,M1,1,0
1,-2.7,GO:1904035,regulation of epithelial cell apoptotic process,M1,1,0
1,-3.6,GO:0050863,regulation of T cell activation,M1,1,0
1,-5.3,GO:0051896,regulation of protein kinase B signaling,M1,1,0
1,-5.3,GO:0001775,cell activation,M1,1,0
1,-3.8,hsa04151,PI3K-Akt signaling pathway,M1,1,0
1,-4.8,M105,PID TELOMERASE PATHWAY,M1,1,0
1,-4.6,WP4255,Non-small cell lung cancer,M1,1,0
1,-3.7,GO:0051347,positive regulation of transferase activity,M1,1,0
1,-2.5,GO:0060560,developmental growth involved in morphogenesis,M1,1,0
1,-5.3,GO:0045596,negative regulation of cell differentiation,M1,1,0
1,-2.2,GO:0021915,neural tube development,M1,1,0
1,-10,GO:0016055,Wnt signaling pathway,M1,1,0
1,-4,GO:0048638,regulation of developmental growth,M1,1,0
1,-2.1,GO:0098609,cell-cell adhesion,M1,1,0
1,-3.7,WP5300,TROP2 regulatory signaling,M1,1,0
1,-3.5,GO:0016331,morphogenesis of embryonic epithelium,M1,1,0
1,-2.5,GO:0048593,camera-type eye morphogenesis,M1,1,0
1,-3.1,GO:0050810,regulation of steroid biosynthetic process,M1,1,0
1,-7,hsa01522,Endocrine resistance,M1,1,0
1,-4,R-HSA-2219528,PI3K/AKT Signaling in Cancer,M1,1,0
1,-6.7,GO:0032870,cellular response to hormone stimulus,M1,1,0
1,-2.9,GO:0019216,regulation of lipid metabolic process,M1,1,0
1,-2.8,hsa04660,T cell receptor signaling pathway,M1,1,0
1,-2.1,GO:0070201,regulation of establishment of protein localization,M1,1,0
1,-6.3,hsa05221,Acute myeloid leukemia,M1,1,0
1,-3.4,GO:0006351,DNA-templated transcription,M1,1,0
1,-6.1,GO:0043010,camera-type eye development,M1,1,0
1,-2.4,GO:0062197,cellular response to chemical stress,M1,1,0
1,-2.3,GO:0002573,myeloid leukocyte differentiation,M1,1,0
1,-3.4,GO:0044057,regulation of system process,M1,1,0
1,-3.6,GO:0048565,digestive tract development,M1,1,0
1,-2.3,GO:0030902,hindbrain development,M1,1,0
1,-2.4,GO:0031667,response to nutrient levels,M1,1,0
1,-18,hsa05165,Human papillomavirus infection,M1,1,0
1,-2.8,R-HSA-422475,Axon guidance,M1,1,0
1,-2.6,GO:0006310,DNA recombination,M1,1,0
1,-3.2,GO:0060415,muscle tissue morphogenesis,M1,1,0
1,-8,WP3931,Embryonic stem cell pluripotency pathways,M1,1,0
1,-2.1,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,M1,1,0
1,-4.2,WP2817,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),M1,1,0
1,-3.3,GO:0032774,RNA biosynthetic process,M1,1,0
1,-4.9,GO:0061448,connective tissue development,M1,1,0
1,-6.4,R-HSA-9006931,Signaling by Nuclear Receptors,M1,1,0
1,-13,hsa04934,Cushing syndrome,M1,1,0
1,-3,hsa04211,Longevity regulating pathway,M1,1,0
1,-4.4,GO:0003338,metanephros morphogenesis,M1,1,0
1,-2.5,GO:0007368,determination of left/right symmetry,M1,1,0
1,-9.3,GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,M1,1,0
1,-3.5,GO:0010718,positive regulation of epithelial to mesenchymal transition,M1,1,0
1,-2.9,GO:0034502,protein localization to chromosome,M1,1,0
1,-2.9,GO:0018193,peptidyl-amino acid modification,M1,1,0
1,-4.6,R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,M1,1,0
1,-11,WP428,Wnt signaling,M1,1,0
1,-10,WP4879,Overlap between signal transduction pathways contributing to LMNA laminopathies,M1,1,0
1,-3.6,R-HSA-2428928,IRS-related events triggered by IGF1R,M1,1,0
1,-3.1,GO:0051222,positive regulation of protein transport,M1,1,0
1,-4.7,GO:0030097,hemopoiesis,M1,1,0
1,-2.5,R-HSA-1257604,PIP3 activates AKT signaling,M1,1,0
1,-10,hsa04550,Signaling pathways regulating pluripotency of stem cells,M1,1,0
1,-3.3,GO:0030098,lymphocyte differentiation,M1,1,0
1,-6.5,GO:0009792,embryo development ending in birth or egg hatching,M1,1,0
1,-2.7,GO:0090263,positive regulation of canonical Wnt signaling pathway,M1,1,0
1,-11,GO:0048568,embryonic organ development,M1,1,0
1,-2.7,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,M1,1,0
1,-11,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,M1,1,0
1,-15,WP4258,lncRNA in canonical Wnt signaling and colorectal cancer,M1,1,0
1,-3.2,GO:0009611,response to wounding,M1,1,0
1,-3.9,GO:0060537,muscle tissue development,M1,1,0
1,-3.8,WP2431,Spinal cord injury,M1,1,0
1,-5.1,GO:1901653,cellular response to peptide,M1,1,0
1,-4.4,GO:0048469,cell maturation,M1,1,0
1,-2.7,GO:0071773,cellular response to BMP stimulus,M1,1,0
1,-3.1,GO:0050865,regulation of cell activation,M1,1,0
1,-3,GO:0005996,monosaccharide metabolic process,M1,1,0
1,-7.4,R-HSA-8939211,ESR-mediated signaling,M1,1,0
1,-5.3,R-HSA-5637810,Constitutive Signaling by EGFRvIII,M1,1,0
1,-2.7,GO:0010717,regulation of epithelial to mesenchymal transition,M1,1,0
1,-4.7,GO:0060485,mesenchyme development,M1,1,0
1,-4.6,R-HSA-9664565,Signaling by ERBB2 KD Mutants,M1,1,0
1,-2.2,GO:0007369,gastrulation,M1,1,0
1,-2.9,GO:0007409,axonogenesis,M1,1,0
1,-4.6,WP4674,Head and neck squamous cell carcinoma,M1,1,0
1,-5.2,GO:0007163,establishment or maintenance of cell polarity,M1,1,0
1,-12,hsa04916,Melanogenesis,M1,1,0
1,-5,R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,M1,1,0
1,-5,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,M1,1,0
1,-2.6,GO:0061564,axon development,M1,1,0
1,-5.3,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,M1,1,0
1,-3.3,GO:1904377,positive regulation of protein localization to cell periphery,M1,1,0
1,-4.1,GO:0030855,epithelial cell differentiation,M1,1,0
1,-2.7,R-HSA-8878171,Transcriptional regulation by RUNX1,M1,1,0
1,-3.5,GO:0030177,positive regulation of Wnt signaling pathway,M1,1,0
1,-3.3,GO:0040017,positive regulation of locomotion,M1,1,0
1,-4.3,GO:0033674,positive regulation of kinase activity,M1,1,0
1,-4.9,R-HSA-4086398,Ca2+ pathway,M1,1,0
1,-2.8,GO:0070997,neuron death,M1,1,0
1,-2.1,GO:0007596,blood coagulation,M1,1,0
1,-3.8,GO:0045444,fat cell differentiation,M1,1,0
1,-3.2,GO:0003205,cardiac chamber development,M1,1,0
1,-2.5,R-HSA-69206,G1/S Transition,M1,1,0
1,-5.2,WP3611,Photodynamic therapy-induced AP-1 survival signaling,M1,1,0
1,-4.5,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,M1,1,0
1,-2.6,GO:0035113,embryonic appendage morphogenesis,M1,1,0
1,-4.2,GO:0071417,cellular response to organonitrogen compound,M1,1,0
1,-4.8,GO:0060713,labyrinthine layer morphogenesis,M1,1,0
1,-8.8,GO:0060021,roof of mouth development,M1,1,0
1,-4.6,WP4216,Chromosomal and microsatellite instability in colorectal cancer,M1,1,0
1,-3.8,GO:0031175,neuron projection development,M1,1,0
1,-2.9,GO:0045995,regulation of embryonic development,M1,1,0
1,-9.3,WP5124,Alzheimer's disease,M1,1,0
1,-3.5,hsa04330,Notch signaling pathway,M1,1,0
1,-4.8,GO:0045682,regulation of epidermis development,M1,1,0
1,-2.1,GO:0050817,coagulation,M1,1,0
1,-3.4,GO:0021700,developmental maturation,M1,1,0
1,-3.9,GO:0001525,angiogenesis,M1,1,0
1,-2.1,GO:1903708,positive regulation of hemopoiesis,M1,1,0
1,-5.3,R-HSA-5637812,Signaling by EGFRvIII in Cancer,M1,1,0
1,-4.7,WP4673,Male infertility,M1,1,0
1,-3.1,GO:0048736,appendage development,M1,1,0
1,-2.7,GO:0072009,nephron epithelium development,M1,1,0
1,-2.2,WP481,Insulin signaling,M1,1,0
1,-3.5,GO:1903078,positive regulation of protein localization to plasma membrane,M1,1,0
1,-2.7,GO:0006941,striated muscle contraction,M1,1,0
1,-5.6,GO:0016444,somatic cell DNA recombination,M1,1,0
1,-2.1,GO:0030217,T cell differentiation,M1,1,0
1,-2.9,GO:0046903,secretion,M1,1,0
1,-3.8,WP5322,CKAP4 signaling pathway map,M1,1,0
1,-2.9,GO:0050878,regulation of body fluid levels,M1,1,0
1,-4.3,GO:0010721,negative regulation of cell development,M1,1,0
1,-3.4,GO:0009746,response to hexose,M1,1,0
1,-6.8,GO:0048660,regulation of smooth muscle cell proliferation,M1,1,0
1,-3,WP4263,Pancreatic adenocarcinoma pathway,M1,1,0
1,-3.2,hsa04010,MAPK signaling pathway,M1,1,0
1,-2.7,GO:0071772,response to BMP,M1,1,0
1,-2,GO:0042176,regulation of protein catabolic process,M1,1,0
1,-2.1,GO:0007276,gamete generation,M1,1,0
1,-3.2,GO:0051216,cartilage development,M1,1,0
1,-4.2,WP4223,Ras signaling,M1,1,0
1,-4,R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",M1,1,0
1,-2,GO:0043087,regulation of GTPase activity,M1,1,0
1,-5.3,GO:0048562,embryonic organ morphogenesis,M1,1,0
1,-2.4,GO:0034329,cell junction assembly,M1,1,0
1,-7.1,R-HSA-373080,Class B/2 (Secretin family receptors),M1,1,0
1,-3.9,GO:0051146,striated muscle cell differentiation,M1,1,0
1,-7.4,GO:0035239,tube morphogenesis,M1,1,0
1,-5.8,GO:0071375,cellular response to peptide hormone stimulus,M1,1,0
1,-2.9,GO:0008016,regulation of heart contraction,M1,1,0
1,-3,GO:0048738,cardiac muscle tissue development,M1,1,0
1,-2.2,GO:0009991,response to extracellular stimulus,M1,1,0
1,-3.4,R-HSA-9018519,Estrogen-dependent gene expression,M1,1,0
1,-2.1,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,M1,1,0
1,-2.5,GO:0007498,mesoderm development,M1,1,0
1,-3.5,GO:0046364,monosaccharide biosynthetic process,M1,1,0
1,-2.2,GO:0071214,cellular response to abiotic stimulus,M1,1,0
1,-3.1,GO:0045913,positive regulation of carbohydrate metabolic process,M1,1,0
1,-2.2,GO:0071560,cellular response to transforming growth factor beta stimulus,M1,1,0
1,-2.9,GO:0045787,positive regulation of cell cycle,M1,1,0
1,-2.9,hsa04510,Focal adhesion,M1,1,0
1,-2.2,GO:0104004,cellular response to environmental stimulus,M1,1,0
1,-3.1,GO:0060173,limb development,M1,1,0
1,-5.6,GO:0090596,sensory organ morphogenesis,M1,1,0
1,-6.6,GO:0000902,cell morphogenesis,M1,1,0
1,-2.4,GO:0003012,muscle system process,M1,1,0
1,-2.5,GO:0003007,heart morphogenesis,M1,1,0
1,-3.3,WP3303,RAC1/PAK1/p38/MMP2 pathway,M1,1,0
1,-2.6,GO:0021761,limbic system development,M1,1,0
1,-2.8,GO:0051402,neuron apoptotic process,M1,1,0
1,-2.5,GO:0003206,cardiac chamber morphogenesis,M1,1,0
1,-2.4,WP2853,Endoderm differentiation,M1,1,0
1,-2.7,GO:1903076,regulation of protein localization to plasma membrane,M1,1,0
1,-4.3,GO:0002521,leukocyte differentiation,M1,1,0
1,-2.1,GO:0051346,negative regulation of hydrolase activity,M1,1,0
1,-3.9,GO:0045637,regulation of myeloid cell differentiation,M1,1,0
1,-8.2,WP4155,Endometrial cancer,M1,1,0
1,-2.8,GO:0006282,regulation of DNA repair,M1,1,0
1,-2.1,GO:0042129,regulation of T cell proliferation,M1,1,0
1,-3.4,GO:0002694,regulation of leukocyte activation,M1,1,0
1,-2.9,GO:0031346,positive regulation of cell projection organization,M1,1,0
1,-3.2,M160,PID AVB3 INTEGRIN PATHWAY,M1,1,0
1,-2.3,GO:0050770,regulation of axonogenesis,M1,1,0
1,-2.7,GO:0032526,response to retinoic acid,M1,1,0
1,-2.3,GO:0060538,skeletal muscle organ development,M1,1,0
1,-5.6,GO:0001568,blood vessel development,M1,1,0
1,-3.7,GO:0051052,regulation of DNA metabolic process,M1,1,0
1,-3.4,GO:2000147,positive regulation of cell motility,M1,1,0
1,-3.3,GO:0034284,response to monosaccharide,M1,1,0
1,-3,GO:0060993,kidney morphogenesis,M1,1,0
1,-2.3,GO:0001822,kidney development,M1,1,0
1,-2.1,GO:0009266,response to temperature stimulus,M1,1,0
1,-5.9,GO:0051960,regulation of nervous system development,M1,1,0
1,-3.1,R-HSA-9013694,Signaling by NOTCH4,M1,1,0
1,-3,GO:0050808,synapse organization,M1,1,0
1,-2.2,GO:0071559,response to transforming growth factor beta,M1,1,0
1,-4.2,GO:1905207,regulation of cardiocyte differentiation,M1,1,0
1,-6.2,WP2882,Nuclear receptors meta-pathway,M1,1,0
1,-2.4,GO:0051384,response to glucocorticoid,M1,1,0
1,-4.6,hsa05223,Non-small cell lung cancer,M1,1,0
1,-2.4,hsa05418,Fluid shear stress and atherosclerosis,M1,1,0
1,-5.4,GO:1902947,regulation of tau-protein kinase activity,M1,1,0
1,-3.3,hsa05161,Hepatitis B,M1,1,0
1,-2,GO:0055082,intracellular chemical homeostasis,M1,1,0
1,-3.7,hsa04926,Relaxin signaling pathway,M1,1,0
1,-2.4,GO:0009855,determination of bilateral symmetry,M1,1,0
1,-2.1,GO:0008361,regulation of cell size,M1,1,0
1,-2.6,GO:0001704,formation of primary germ layer,M1,1,0
1,-2,GO:0046777,protein autophosphorylation,M1,1,0
1,-5.9,GO:0040008,regulation of growth,M1,1,0
1,-6.6,GO:0050767,regulation of neurogenesis,M1,1,0
1,-3.4,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,M1,1,0
1,-3.5,GO:0030335,positive regulation of cell migration,M1,1,0
1,-3,hsa05202,Transcriptional misregulation in cancer,M1,1,0
1,-5.5,GO:0070848,response to growth factor,M1,1,0
1,-5.7,GO:0001892,embryonic placenta development,M1,1,0
1,-4.7,GO:0051098,regulation of binding,M1,1,0
1,-2.8,GO:0051153,regulation of striated muscle cell differentiation,M1,1,0
1,-3,GO:0044089,positive regulation of cellular component biogenesis,M1,1,0
1,-2.1,R-HSA-73894,DNA Repair,M1,1,0
1,-3.5,GO:0042063,gliogenesis,M1,1,0
1,-3,GO:0021543,pallium development,M1,1,0
1,-26,WP4262,Breast cancer pathway,M1,1,0
1,-4.1,GO:0008285,negative regulation of cell population proliferation,M1,1,0
1,-2.8,hsa05231,Choline metabolism in cancer,M1,1,0
1,-4.3,GO:0048732,gland development,M1,1,0
1,-10,GO:0198738,cell-cell signaling by wnt,M1,1,0
1,-2.8,GO:1903037,regulation of leukocyte cell-cell adhesion,M1,1,0
1,-2.6,hsa05132,Salmonella infection,M1,1,0
1,-4.5,GO:0008283,cell population proliferation,M1,1,0
1,-2.7,GO:0006259,DNA metabolic process,M1,1,0
1,-20,hsa05226,Gastric cancer,M1,1,0
1,-7.7,WP4150,Wnt signaling in kidney disease,M1,1,0
1,-6,R-HSA-4791275,Signaling by WNT in cancer,M1,1,0
1,-11,GO:0062009,secondary palate development,M1,1,0
1,-2.6,GO:0032989,cellular component morphogenesis,M1,1,0
1,-2.4,WP2858,Ectoderm differentiation,M1,1,0
1,-4.2,hsa04520,Adherens junction,M1,1,0
1,-3.5,GO:0032648,regulation of interferon-beta production,M1,1,0
1,-2.4,GO:0072073,kidney epithelium development,M1,1,0
1,-3.7,GO:0010817,regulation of hormone levels,M1,1,0
1,-4.6,GO:0050768,negative regulation of neurogenesis,M1,1,0
1,-5.6,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,M1,1,0
1,-7.2,GO:0033151,V(D)J recombination,M1,1,0
1,-2.5,GO:0043547,positive regulation of GTPase activity,M1,1,0
1,-2.9,GO:0046889,positive regulation of lipid biosynthetic process,M1,1,0
1,-4.9,GO:0007420,brain development,M1,1,0
1,-2.9,GO:0042593,glucose homeostasis,M1,1,0
1,-5,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,M1,1,0
1,-3.3,M255,PID HIF1 TFPATHWAY,M1,1,0
1,-6.9,hsa05022,Pathways of neurodegeneration - multiple diseases,M1,1,0
1,-4.1,GO:1901652,response to peptide,M1,1,0
1,-2.4,GO:0007519,skeletal muscle tissue development,M1,1,0
1,-3,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,M1,1,0
1,-3,GO:0022407,regulation of cell-cell adhesion,M1,1,0
1,-2.2,GO:0051494,negative regulation of cytoskeleton organization,M1,1,0
1,-3.3,GO:0008286,insulin receptor signaling pathway,M1,1,0
1,-2.7,GO:0003279,cardiac septum development,M1,1,0
1,-2.5,GO:1903522,regulation of blood circulation,M1,1,0
1,-3.5,M166,PID ATF2 PATHWAY,M1,1,0
1,-3.2,hsa04630,JAK-STAT signaling pathway,M1,1,0
1,-2.4,GO:0072006,nephron development,M1,1,0
1,-4.8,GO:0000904,cell morphogenesis involved in differentiation,M1,1,0
1,-3.6,hsa04068,FoxO signaling pathway,M1,1,0
1,-8.1,GO:0045165,cell fate commitment,M1,1,0
1,-7.3,GO:0022009,central nervous system vasculogenesis,M1,1,0
1,-3,GO:0007626,locomotory behavior,M1,1,0
1,-4,GO:0046649,lymphocyte activation,M1,1,0
1,-3.7,GO:0019319,hexose biosynthetic process,M1,1,0
1,-2.8,M5885,NABA MATRISOME ASSOCIATED,M1,1,0
1,-2.2,GO:0051223,regulation of protein transport,M1,1,0
1,-2.8,GO:0045619,regulation of lymphocyte differentiation,M1,1,0
1,-3.7,R-HSA-1227986,Signaling by ERBB2,M1,1,0
1,-13,hsa04310,Wnt signaling pathway,M1,1,0
1,-3.8,GO:0048640,negative regulation of developmental growth,M1,1,0
1,-2,R-HSA-2990846,SUMOylation,M1,1,0
1,-5.4,WP1544,MicroRNAs in cardiomyocyte hypertrophy,M1,1,0
1,-2.3,GO:0090316,positive regulation of intracellular protein transport,M1,1,0
1,-3.7,GO:0006094,gluconeogenesis,M1,1,0
1,-4.6,GO:0043434,response to peptide hormone,M1,1,0
1,-3.8,GO:0051249,regulation of lymphocyte activation,M1,1,0
1,-4.5,GO:0001701,in utero embryonic development,M1,1,0
1,-2.7,R-HSA-9675108,Nervous system development,M1,1,0
1,-2,GO:0071902,positive regulation of protein serine/threonine kinase activity,M1,1,0
1,-4.9,R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,M1,1,0
1,-3.1,GO:0051276,chromosome organization,M1,1,0
1,-3.2,GO:0043627,response to estrogen,M1,1,0
1,-2.2,GO:0061138,morphogenesis of a branching epithelium,M1,1,0
1,-2.7,GO:0007416,synapse assembly,M1,1,0
1,-3.4,GO:0097659,nucleic acid-templated transcription,M1,1,0
1,-3.9,R-HSA-199418,Negative regulation of the PI3K/AKT network,M1,1,0
1,-3.3,WP4685,Melanoma,M1,1,0
1,-5.1,hsa05203,Viral carcinogenesis,M1,1,0
1,-2.1,GO:0010634,positive regulation of epithelial cell migration,M1,1,0
1,-3.4,GO:0002763,positive regulation of myeloid leukocyte differentiation,M1,1,0
1,-2.9,GO:0030509,BMP signaling pathway,M1,1,0
1,-3.3,hsa04917,Prolactin signaling pathway,M1,1,0
1,-3.8,GO:0050679,positive regulation of epithelial cell proliferation,M1,1,0
1,-2.7,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,M1,1,0
1,-2.4,GO:0044283,small molecule biosynthetic process,M1,1,0
1,-5,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,M1,1,0
1,-10,hsa04150,mTOR signaling pathway,M1,1,0
1,-10,GO:0060070,canonical Wnt signaling pathway,M1,1,0
1,-2.1,GO:0006109,regulation of carbohydrate metabolic process,M1,1,0
1,-2.5,GO:0048232,male gamete generation,M1,1,0
1,-4,GO:0045445,myoblast differentiation,M1,1,0
1,-4.1,GO:0006338,chromatin remodeling,M1,1,0
1,-6.8,GO:0042327,positive regulation of phosphorylation,M1,1,0
1,-3.5,WP4816,TGF-beta receptor signaling in skeletal dysplasias,M1,1,0
1,-2.3,GO:0035107,appendage morphogenesis,M1,1,0
1,-3.3,M167,PID AP1 PATHWAY,M1,1,0
1,-8.3,M77,PID WNT SIGNALING PATHWAY,M1,1,0
1,-6.8,GO:0033138,positive regulation of peptidyl-serine phosphorylation,M1,1,0
1,-3.2,GO:0048812,neuron projection morphogenesis,M1,1,0
1,-2,GO:0071466,cellular response to xenobiotic stimulus,M1,1,0
1,-3,hsa04012,ErbB signaling pathway,M1,1,0
1,-3.8,hsa04152,AMPK signaling pathway,M1,1,0
1,-5,R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,M1,1,0
1,-3.4,GO:0062013,positive regulation of small molecule metabolic process,M1,1,0
1,-3.5,GO:0090090,negative regulation of canonical Wnt signaling pathway,M1,1,0
1,-3.7,GO:0042471,ear morphogenesis,M1,1,0
1,-4.5,GO:0051961,negative regulation of nervous system development,M1,1,0
1,-2.3,R-HSA-9006925,Intracellular signaling by second messengers,M1,1,0
1,-3.3,WP3888,VEGFA-VEGFR2 signaling,M1,1,0
1,-4.9,GO:1903829,positive regulation of protein localization,M1,1,0
1,-2.4,GO:0019725,cellular homeostasis,M1,1,0
1,-4.3,GO:1903706,regulation of hemopoiesis,M1,1,0
1,-4.2,WP4746,Thyroid hormones production and peripheral downstream signaling effects,M1,1,0
1,-6.1,GO:0046328,regulation of JNK cascade,M1,1,0
1,-10,hsa05205,Proteoglycans in cancer,M1,1,0
1,-2.4,GO:1900180,regulation of protein localization to nucleus,M1,1,0
1,-2.8,GO:0033500,carbohydrate homeostasis,M1,1,0
1,-2.8,GO:0120162,positive regulation of cold-induced thermogenesis,M1,1,0
1,-2.5,hsa04650,Natural killer cell mediated cytotoxicity,M1,1,0
1,-4,GO:0045823,positive regulation of heart contraction,M1,1,0
1,-3.5,R-HSA-3858494,Beta-catenin independent WNT signaling,M1,1,0
1,-12,WP4336,ncRNAs involved in Wnt signaling in hepatocellular carcinoma,M1,1,0
1,-4.3,GO:0050678,regulation of epithelial cell proliferation,M1,1,0
1,-2.6,WP4541,Hippo-Merlin signaling dysregulation,M1,1,0
1,-3.3,GO:0048708,astrocyte differentiation,M1,1,0
1,-3.6,GO:0035567,non-canonical Wnt signaling pathway,M1,1,0
1,-5.1,GO:0072132,mesenchyme morphogenesis,M1,1,0
1,-4.9,R-HSA-500792,GPCR ligand binding,M1,1,0
1,-3.2,GO:0060411,cardiac septum morphogenesis,M1,1,0
1,-7.2,R-HSA-195721,Signaling by WNT,M1,1,0
1,-8.9,M5493,WNT SIGNALING,M1,1,0
1,-7.8,GO:0150063,visual system development,M1,1,0
1,-5.4,GO:0060711,labyrinthine layer development,M1,1,0
1,-5.2,GO:0002200,somatic diversification of immune receptors,M1,1,0
1,-4.9,GO:0045859,regulation of protein kinase activity,M1,1,0
1,-2.5,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,M1,1,0
1,-3.6,GO:0007173,epidermal growth factor receptor signaling pathway,M1,1,0
1,-4.7,GO:0061311,cell surface receptor signaling pathway involved in heart development,M1,1,0
1,-3.5,GO:0043388,positive regulation of DNA binding,M1,1,0
1,-2.1,GO:0001763,morphogenesis of a branching structure,M1,1,0
1,-4.5,hsa01521,EGFR tyrosine kinase inhibitor resistance,M1,1,0
1,-4.5,GO:0051147,regulation of muscle cell differentiation,M1,1,0
1,-3.4,WP2857,Mesodermal commitment pathway,M1,1,0
1,-2.8,GO:0043523,regulation of neuron apoptotic process,M1,1,0
1,-2.3,GO:0048608,reproductive structure development,M1,1,0
1,-3.8,GO:0006366,transcription by RNA polymerase II,M1,1,0
1,-10,GO:0003002,regionalization,M1,1,0
1,-4.8,hsa04915,Estrogen signaling pathway,M1,1,0
1,-3.1,GO:0002064,epithelial cell development,M1,1,0
1,-3.2,GO:0030178,negative regulation of Wnt signaling pathway,M1,1,0
1,-3.5,GO:0055123,digestive system development,M1,1,0
1,-4.7,R-HSA-9793380,Formation of paraxial mesoderm,M1,1,0
1,-4.1,GO:0042472,inner ear morphogenesis,M1,1,0
1,-5.3,GO:1905208,negative regulation of cardiocyte differentiation,M1,1,0
1,-2.2,GO:0022409,positive regulation of cell-cell adhesion,M1,1,0
1,-2.6,GO:0035051,cardiocyte differentiation,M1,1,0
1,-5.2,WP3932,Focal adhesion: PI3K-Akt-mTOR-signaling pathway,M1,1,0
1,-2.3,GO:0045807,positive regulation of endocytosis,M1,1,0
1,-3.6,GO:0009948,anterior/posterior axis specification,M1,1,0
1,-3,hsa04540,Gap junction,M1,1,0
1,-3.4,GO:0048871,multicellular organismal-level homeostasis,M1,1,0
1,-3.3,WP2032,Thyroid stimulating hormone (TSH) signaling pathway,M1,1,0
1,-2.2,GO:0032787,monocarboxylic acid metabolic process,M1,1,0
1,-3.8,hsa05166,Human T-cell leukemia virus 1 infection,M1,1,0
1,-2.6,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,M1,1,0
1,-2.2,GO:0051251,positive regulation of lymphocyte activation,M1,1,0
1,-3.2,GO:0120039,plasma membrane bounded cell projection morphogenesis,M1,1,0
1,-3,GO:0014706,striated muscle tissue development,M1,1,0
1,-3.7,GO:0043457,regulation of cellular respiration,M1,1,0
1,-3.2,GO:0043086,negative regulation of catalytic activity,M1,1,0
1,-3,GO:0001656,metanephros development,M1,1,0
1,-2.7,GO:0050670,regulation of lymphocyte proliferation,M1,1,0
1,-3.2,GO:0031960,response to corticosteroid,M1,1,0
1,-3.1,GO:0060562,epithelial tube morphogenesis,M1,1,0
1,-5.1,GO:0051101,regulation of DNA binding,M1,1,0
1,-3.4,GO:0021537,telencephalon development,M1,1,0
1,-5.3,R-HSA-9012852,Signaling by NOTCH3,M1,1,0
1,-2.9,hsa05222,Small cell lung cancer,M1,1,0
1,-2.7,hsa04020,Calcium signaling pathway,M1,1,0
1,-3.7,GO:0043408,regulation of MAPK cascade,M1,1,0
1,-2.9,GO:0045814,"negative regulation of gene expression, epigenetic",M1,1,0
1,-2.3,GO:0072001,renal system development,M1,1,0
1,-8.4,hsa05213,Endometrial cancer,M1,1,0
1,-8.4,WP399,Wnt signaling pathway and pluripotency,M1,1,0
1,-3.7,R-HSA-157118,Signaling by NOTCH,M1,1,0
1,-3,GO:0042060,wound healing,M1,1,0
1,-2.6,WP382,MAPK signaling pathway,M1,1,0
1,-2.3,GO:0043524,negative regulation of neuron apoptotic process,M1,1,0
1,-2.5,GO:0030879,mammary gland development,M1,1,0
1,-2.9,GO:0055007,cardiac muscle cell differentiation,M1,1,0
1,-2.4,GO:0001101,response to acid chemical,M1,1,0
1,-8.5,WP2064,Neural crest differentiation,M1,1,0
1,-4.5,GO:0080135,regulation of cellular response to stress,M1,1,0
1,-4.2,GO:1901214,regulation of neuron death,M1,1,0
1,-4.1,GO:0003230,cardiac atrium development,M1,1,0
1,-11,GO:0007389,pattern specification process,M1,1,0
1,-3,hsa05167,Kaposi sarcoma-associated herpesvirus infection,M1,1,0
1,-3.3,WP706,Sudden infant death syndrome (SIDS) susceptibility pathways,M1,1,0
1,-2.8,GO:0061351,neural precursor cell proliferation,M1,1,0
1,-5.8,WP4844,Influence of laminopathies on Wnt signaling,M1,1,0
1,-5.7,GO:0061061,muscle structure development,M1,1,0
1,-4.5,GO:0060669,embryonic placenta morphogenesis,M1,1,0
1,-6.1,R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,M1,1,0
1,-4.6,R-HSA-1980143,Signaling by NOTCH1,M1,1,0
1,-2.6,GO:0032479,regulation of type I interferon production,M1,1,0
